Ekaterina Protsenko

Часть публикаций из профиля, по году от новых к старым. Это не полный список последних работ автора; работы без года — в конце.

• Immunogenicity, efficacy and safety of a biosimilar insulin glulisine compared with originator in adults with type 1 diabetes mellitus: A phase III randomised clinical trial2025
• Author response for "Immunogenicity, Efficacy, and Safety of a Biosimilar Insulin Glulisine Compared With Originator in Adults with Type 1 Diabetes Mellitus: A Phase III Randomized Clinical Trial"2025
• Multicenter Single‐Blind Randomized Controlled Trial of the Romiplostim Biosimilar2025
• Bioequivalence and Safety of Generic Glecaprevir/Pibrentasvir Compared to a Branded Product: A Randomized, Crossover Study in Healthy Volunteers2024
• Clinical Pharmacology of GP40321 (Insulin Glulisine Biosimilar): Pharmacokinetic and Pharmacodynamic Comparability in a Hyperinsulinemic‐Euglycemic Clamp Procedure2024
• “GrimAge,” an epigenetic predictor of mortality, is accelerated in major depressive disorder2021 · аннотациясвернуть

  Major depressive disorder (MDD) is associated with premature mortality and is an independent risk factor for a broad range of diseases, especially those associated with aging, such as cardiovascular disease, diabetes,…

• In-vivo imaging of neuroinflammation in veterans with Gulf War illness2020 · аннотациясвернуть

  Gulf War Illness (GWI) is a chronic disorder affecting approximately 30% of the veterans who served in the 1991 Gulf War. It is characterised by a constellation of symptoms including musculoskeletal pain, cognitive…

• The neuroinflammatory component of negative affect in patients with chronic pain2019